COVID-19 Vaccine Safety: From Bench to Bedside


COVID-19 Vaccine Safety: From Bench to Bedside

21 May 2021


Within a year of the pandemic being announced, several COVID-19 vaccines were approved and administered to populations around the world. There have been various successes and challenges related to the development and deployment of COVID-19 vaccines and there is significant global interest in ensuring they are safe and effective. Healthcare professionals need credible information to build trust with their patients and answer their questions.

Asian Development Bank and BMJ experts discussed COVID-19 vaccine safety in clinical trials, post-authorization safety methods, and risk communication.

This free webinar was part of the BMJ/ADB COVID-19 Information Centre, providing updated clinical decision support from BMJ Best Practice and e-learning resources from BMJ Learning to frontline healthcare professionals.



Dr. Patrick L. Osewe, Chief of Health Sector Group, Asian Development Bank

Dr. Stephen Prior, Microbiologist, and President of Therax, Inc., USA

Dr. Daniel Salmon, Director of the Institute for Vaccine Safety, John Hopkins Bloomberg School of Public Health, USA

Dr. Priscilla Rupali, Infectious diseases physician and Professor, Department of Infectious Diseases, Christian Medical College, Vellore, India


Dr. Kieran Walsh, Clinical Director, BMJ

Program and Learning Materials: 
Date Session / Activity Presentation Material Speaker(s)
21 May 2021 Presentation 1 SARS-CoV-2 and COVID-19 Clinical Trials and Vaccine Safety
Dr. Stephen Prior shared hisinsight on vaccination, vaccine safety, and efficacy. He also discussed the comparison of vaccine development processesandCOVID...
Stephen Prior
21 May 2021 Presentation 2 Post-Authorization Safety Monitoring
This presentation gives an overview of Dr. Salmon's presentation on why safety monitoring is important after vaccination. Dr. Salmon also shared insights...
Daniel Salmon
21 May 2021 Presentation 3 Risk Communication: COVID-19 Vaccine
Dr. Priscilla Rupali, in this presentation, shared insights on risk communications that emerged from the COVID-19 pandemic and how it has impacted the...
Priscilla Rupali


The views expressed on this website are those of the authors and do not necessarily reflect the views and policies of the Asian Development Bank (ADB) or its Board of Governors or the governments they represent. ADB does not guarantee the accuracy of the data included in this publication and accepts no responsibility for any consequence of their use. By making any designation of or reference to a particular territory or geographic area, or by using the term “country” in this document, ADB does not intend to make any judgments as to the legal or other status of any territory or area.